Laura D. Osellame

Heidelberg, VIC 3084, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection.

Mitochondrial Dynamic Proteins MiD49 and MiD51 as Novel Targets of Cardioprotection.

Journal: Cells

Published: November 30, 2025

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.

Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: November 11, 2025

Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.

Characterisation of mAb104 Antibody-Drug Conjugates Targeting a Tumour-Selective HER2 Epitope.

Journal: Cancers

Published: August 21, 2025

Clinical development of tri-specific antibodies for immune-oncology.

Clinical development of tri-specific antibodies for immune-oncology.

Journal: Expert opinion on investigational drugs

Published: May 23, 2025

DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma.

DNA-Dependent Protein Kinase Inhibitor Peposertib Enhances Efficacy of 177Lu-Based Radioimmunotherapy in Preclinical Models of Prostate and Renal Cell Carcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 26, 2024

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2.

Journal: Molecular cancer therapeutics

Published: July 15, 2024

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.

Journal: Journal of biomedical science

Published: April 05, 2024

Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.

Targeting Fn14 as a therapeutic target for cachexia reprograms the glycolytic pathway in tumour and brain in mice.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 16, 2024

Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX.

Tumor targeted alpha particle therapy with an actinium-225 labelled antibody for carbonic anhydrase IX.

Journal: Chemical science

Published: November 28, 2023

Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB.

Radiolabelling and preclinical characterisation of [89Zr]Zr-Df-ATG-101 bispecific to PD-L1/4-1BB.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 14, 2023

Antibody drug conjugates for glioblastoma: current progress towards clinical use.

Antibody drug conjugates for glioblastoma: current progress towards clinical use.

Journal: Expert opinion on biological therapy

Published: November 13, 2023

Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.

Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: October 29, 2023

Showing 1-12 of 30

Last Updated: 09/26/2026